Does BENDAMUSTINE Cause Basal cell carcinoma? 137 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 137 reports of Basal cell carcinoma have been filed in association with BENDAMUSTINE (VIVIMUSTA). This represents 0.7% of all adverse event reports for BENDAMUSTINE.
137
Reports of Basal cell carcinoma with BENDAMUSTINE
0.7%
of all BENDAMUSTINE reports
2
Deaths
59
Hospitalizations
How Dangerous Is Basal cell carcinoma From BENDAMUSTINE?
Of the 137 reports, 2 (1.5%) resulted in death, 59 (43.1%) required hospitalization, and 16 (11.7%) were considered life-threatening.
Is Basal cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BENDAMUSTINE. However, 137 reports have been filed with the FAERS database.
What Other Side Effects Does BENDAMUSTINE Cause?
Off label use (2,578)
Disease progression (2,456)
Pyrexia (1,322)
Neutropenia (1,256)
Drug ineffective (1,135)
Febrile neutropenia (1,005)
Pneumonia (975)
Thrombocytopenia (967)
Covid-19 (892)
Anaemia (817)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
Which BENDAMUSTINE Alternatives Have Lower Basal cell carcinoma Risk?
BENDAMUSTINE vs BENDROFLUMETHIAZIDE
BENDAMUSTINE vs BENIDIPINE
BENDAMUSTINE vs BENLYSTA
BENDAMUSTINE vs BENRALIZUMAB
BENDAMUSTINE vs BENSERAZIDE